ArchPoint Investors’s Pfizer PFE Stock Holding History

ArchPoint Investors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,547	Closed	-$239K	–	113
2021 Q3	$239K	Buy	+5,547	New	+$246K	0.07%	90
2020 Q2	–	Sell	-25,454	Closed	-$788K	–	123
2020 Q1	$788K	Buy	25,454 +5,296	+26%	+$180K	0.31%	34
2019 Q4	$749K	Hold	20,158	–	–	0.23%	50
2019 Q3	$687K	Sell	20,158 -364	-2%	-$13.2K	0.23%	43
2019 Q2	$843K	Hold	20,522	–	–	0.27%	39
2019 Q1	$827K	Sell	20,522 -85	-0.4%	-$3.4K	0.25%	38
2018 Q4	$853K	Sell	20,607 -1,265	-6%	-$52.5K	0.3%	35
2018 Q3	$914K	Hold	21,872	–	–	0.25%	47
2018 Q2	$753K	Sell	21,872 -2,656	-11%	-$90.8K	0.22%	49
2018 Q1	$826K	Hold	24,528	–	–	0.24%	48
2017 Q4	$843K	Hold	24,528	–	–	0.26%	42
2017 Q3	$830K	Buy	24,528 +4,290	+21%	+$138K	0.26%	47
2017 Q2	$645K	Hold	20,238	–	–	0.21%	57
2017 Q1	$654K	Sell	20,238 -585	-3%	-$18.4K	0.25%	43
2016 Q4	$641K	Buy	20,823 +9,270	+80%	+$283K	0.38%	36
2016 Q3	$372K	Hold	11,553	–	–	0.21%	65
2016 Q2	$386K	Sell	11,553 -1,739	-13%	-$55.5K	0.22%	58
2016 Q1	$374K	Buy	13,292 +12,927	+3,542%	+$369K	0.2%	62
2015 Q4	$11K	Buy	+365	New	+$11.5K	0.01%	131

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

ArchPoint Investors's PFE Position: Q4 2021 in Review

ArchPoint Investors sold out of Pfizer (PFE) in Q4 2021, closing a stake of 5,547 shares — an estimated $239K sold.

ArchPoint Investors first reported a position in PFE in Q4 2015 and held it in 19 quarters. The position peaked at $914K in Q3 2018. 3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

ArchPoint Investors reported no remaining Pfizer position as of Q4 2021 after selling out during the quarter.
ArchPoint Investors sold 5,547 Pfizer shares in Q4 2021, an estimated $239K.
ArchPoint Investors first reported a position in Pfizer in Q4 2015 and held it in 19 quarters.
ArchPoint Investors's Pfizer position peaked at $914K in Q3 2018.
3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on ArchPoint Investors's 13F filing for Q4 2021, filed 11 Feb 2022.